The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. (Editorial)
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/strike-against-pharma-mncs
[2] http://admin.indiaenvironmentportal.org.in/category/journal/economic-and-political-weekly
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/multicorporations
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/cancer
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/germany
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/bayer-pharmaceuticals
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/patents